Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Rishi R Lulla
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
131 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hima San Pablo Oncologic Hospital
Caguas, Puerto Rico
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Banner Children'S at Desert
Mesa, Arizona, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Memorial Regional Hospital/joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Sacred Heart Hospital
Pensacola, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph'S Hospital/children'S Hospital-Tampa
Tampa, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Saint Mary'S Medical Center
West Palm Beach, Florida, United States
- Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Feb 2020
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 3 Nov 2026
- Registered enrollment
- 58
- Registry id
- NCT03919071
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.